Opdivo (nivolumab)
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Opdivo (nivolumab), covering 2022-02-09 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland